Skip Navigation

Foodborne Pathogens and Disease

Not a subscriber? Get started...

Economic Costs of Shiga Toxin–Producing Escherichia coli Infection in Australia

To cite this article:
Michelle McPherson, Martyn D. Kirk, Jane Raupach, Barry Combs, and Jim R.G. Butler. Foodborne Pathogens and Disease. January 2011, 8(1): 55-62. doi:10.1089/fpd.2010.0608.

Published in Volume: 8 Issue 1: January 8, 2011
Online Ahead of Print: November 17, 2010

Author information

Michelle McPherson,1 Martyn D. Kirk,2,3 Jane Raupach,1 Barry Combs,4 and Jim R.G. Butler5
1OzFoodNet, Department of Health, Adelaide, South Australia, Australia.
2OzFoodNet, Office of Health Protection, Department of Health and Ageing, Canberra, Australia.
3National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia.
4Department of Health, Perth, Western Australia, Australia.
5Australian Centre for Economic Research on Health, The Australian National University, Canberra, Australia.
Address correspondence to:
Martyn D. Kirk, B.App.Sci., M.App.Epid.
OzFoodNet, Office of Health Protection
Department of Health and Ageing
GPO Box 9848, MDP 14
Canberra 2601
Australian Capital Territory
Australia
E-mail:

ABSTRACT

Abstract

Shiga toxin–producing Escherichia coli (STEC) infections are an important cause of foodborne disease in Australia. Three percent to 7% of sporadic patients develop hemolytic uremic syndrome (HUS) and 40% of patients with HUS develop chronic complications. To examine costs associated with illness, we interviewed patients notified to the South Australian Department of Health with a structured questionnaire regarding severity of illness, medical treatment, time lost from work, hospitalization, and other costs. In 2003–2006, we interviewed 46 patients of STEC infection, 2 of whom developed HUS. The median duration of illness was 7 days (range 3–31 days) and 41% (19/46) of patients were admitted to hospital. The estimated total cost for the 46 STEC cases in South Australia was AUD$144,087, equating to a mean cost of AUD$3132 per case. We estimate that the annual total costs of STEC infection in South Australia and Australia are AUD$200,283 and AUD$2,633,181, respectively. We used linear regression to identify that STEC infection costs increase by AUD$608 per day regardless of severity, and that more severe illness is strong predictor of cost. This is the first Australian study to examine costs of STEC infection and highlights the significant impact of this illness.

Users who read this article also read

no access
Mar Masiá, Sergio Padilla, Catalina Robledano, Natividad López, José Manuel Ramos, Felix Gutiérrez
AIDS Research and Human Retroviruses. March 2012: 242-246.
Abstract | Full Text PDF or HTML | Reprints | Permissions
no access
Rustam Kudyakov, James Bowen, Edward Ewen, Suzanne L. West, Yahya Daoud, Neil Fleming, Andrew Masica
Population Health Management. February 2012: 3-11.
Abstract | Full Text PDF or HTML | Reprints | Permissions
no access
Desmond Barry Keenan, John Joseph Mastrototaro, Howard Zisser, Kenneth A. Cooper, Gautham Raghavendhar, Scott W. Lee, Jonathan Yusi, Timothy S. Bailey, Ronald Leonard Brazg, Rajiv V. Shah
Diabetes Technology & Therapeutics. March 2012: 225-231.
Abstract | Full Text PDF or HTML | Reprints | Permissions
no access
Andrew Prendergast, Maria O'Callaghan, Esse Menson, Djamel Hamadache, Sam Walters, Nigel Klein, Philip Goulder
AIDS Research and Human Retroviruses. May 2012: 465-468.
Abstract | Full Text PDF or HTML | Reprints | Permissions
no access
Mutasem El-Fadel, Layale Abi-Esber, Naim Salem
Environmental Engineering Science. March 2012: 161-173.
Abstract | Full Text PDF or HTML | Reprints | Permissions
no access
Stéphanie Becker, Nicolas Lepareur, Virginie Cadeillan, Valérie Ardisson, Sahar Bayat, Nicolas Noiret, Etienne Garin
Cancer Biotherapy & Radiopharmaceuticals. March 2012: 149-155.
Abstract | Full Text PDF or HTML | Reprints | Permissions

Sign up for TOC Alerts


Publication Tools

Search:

for

Authors:

Keyword:

Go to Advanced Search